Matthias Bräutigam

Preclinical Development, R&D Strategies

CONELIS expert Matthias Bräutigam

Advisor, Pharma R&D Consult

Berlin

German, English

Services offered worldwide

Contact Me

Send me an Turn on Javascript!

Offers

  • Research and Early Development,
  • Imaging Diagnostics

About Me

After my state examination in Medicine I devoted to pharmacological research and early drug development. I worked almost 10 years in academic pharmacological research, specialized as Medical Pharmacologist (in CNS pharmacology) and received a professorship in Pharmacology at the Free University of Berlin. My academic carrier was followed by 20 years mainly in research functions at Bayer Schering Pharma, Berlin. There, I was responsible for various indication areas, as Drug Research in Dermatology, in Steroid Receptor Agonists and in Imaging Agents in addition I headed General Pharmacology including Safety Pharmacology. The last 7 years I was the head of Imaging Research.

I stayed one year at Indiana University in the US, and worked 4 years for Schering in Japan as member of the Board being responsible for R&D including regulatory drug approval. I have a broad network of academic and industry experts. Being open-minded, one of my strength is certainly a quick perception of a research project and its issues and my understanding of the language of the various experts and my ability to bring them together - at least sometimes.

Presently I am working as advisor for Drug Research and Early Development, in addition I co-own Research&Development-devoted GmbHs in Berlin.

Qualifications

1977 Medical Doctor
1985 Board Certified MD for Pharmcology
1986 Habilitation in Pharmacology
2000 Professor for Pharmacology (Freie University Berlin)

Education:

Medicine at the Freie University, Berlin
Scholarship Indiana University (Physiology)
Internship in Internal Medicine and Surgery

Experience:

10 years academic research in CNS pharmacology
20 years in the Pharmaceutical Industry (Dermatology, Osteporosis, Imaging Agents and Imaging Technogies, Medical Devices, General Pharmacology)

  • 1996-00 Head of Research and Development Nihon Schering, Japan
  • 1997-00 Board member, Nihon Schering
  • 2000-05 Supervisory Board Combinature AG
  • 2000-08 Head of Imaging Research at Schering AG/Bayer Schering Pharma AG
  • 2001-05 Beirat Forschungsinstitut Molekulare Pharmakologie, Berlin
  • 2002- Member Stiftungsrat "Japanisch Deutsches Zentrum Berlin"
  • 2005- Member of Net-Work Drug Discovery and Develovment NetDDD Berlin-Brandenburg
  • 2008- Pharma R&D Consult
  • 2008- Geschäftsführer invivoContrast GmbH

Areas of Expertise:

Preclinical Development, R&D Strategies